A brief note on ACA implementation hurdles and delays
Maybe I’m observing a skewed slice of the media, but it seems like many are blaming ACA implementation issues and delays on the Obama Administration
Maybe I’m observing a skewed slice of the media, but it seems like many are blaming ACA implementation issues and delays on the Obama Administration
A long-standing and important question about Medicare Advantage (MA) is the extent to which outcomes for beneficiaries who enroll in participating private plans are due
In secret, during “trade” negotiations. Just one example: the 12 years of data exclusivity for biologics is currently US law, but that may get carved
From HSR, “Increased Risk of Death among Uninsured Neonates“: Objective: To estimate the contribution of health insurance status to the risk of death among hospitalized neonates.
I came out of holiday weekend hiding to collect my thoughts on the employer penalty delay and write them for CNN.com. Go read! @aaronecarroll
As has been documented on this blog before, VA drug prices are below those of Medicare’s Part D plans. The VA also spends less than
Because the Supreme Court declined to strike down the Affordable Care Act in toto, one might forget how audacious its decision actually was. Its decision
Something I pointed out months ago got a new life on Twitter yesterday. Here’s the idea: Imagine, in 2014, you are a person desiring health
Yes, it’s a slide in a library. More here. @afrakt
According to a recent paper by Joel Weissman, Christine Vogeli, and Douglas Levy, process quality measures are lower for Medicaid enrollees who are hospitalized for myocardial
I’ve done some reading. Here are a few kidney stones-related facts from the literature: 13% of men and 7% of women get kidney stones in
David Lazarus is a reporter on consumer issues for the LA Times. His family recently became big-time consumers of health when his wife spent a